This inventor holds 2 USPTO granted patents. Top assignee: Max-Delbruck-Centrum Fur Molekulare Medizin (Mdc) Berlin-Buch. Active years: 2019-2025.
Company Filing History:
Years Active: 2019-2025
Title: Catarina Leitão: Innovator in Cancer Immunotherapy
Introduction
Catarina Leitão is a prominent inventor based in Lisbon, Portugal. She has made significant contributions to the field of cancer immunotherapy, particularly through her innovative research and patented technologies. With a total of 2 patents, her work focuses on developing high avidity antigen recognizing constructs that can be utilized in the diagnosis and treatment of tumorous diseases.
Latest Patents
Catarina's latest patents include groundbreaking inventions related to high avidity antigen recognizing constructs. These constructs, which encompass antibodies and T cell receptors, are designed to specifically bind to the melanoma-associated antigen (MAGE) A1. The significance of these constructs lies in their potential applications for the diagnosis, prevention, and therapy of cancers characterized by the expression of the MAGE-A1 antigen. Additionally, her inventions provide nucleic acids, vectors, and host cells, such as CD4 or CD8 positive T cells, that encode or present these antigen recognizing constructs. This innovative approach offers new avenues for immune therapy, particularly in the realm of adoptive T cell therapy for cancer treatment.
Career Highlights
Catarina Leitão is currently affiliated with the Max-Delbruck-Centrum für Molekulare Medizin (MDC) in Berlin-Buch. Her work at this esteemed research institution has allowed her to explore and develop novel therapeutic strategies aimed at combating cancer. Her dedication to advancing medical science is evident in her research and the patents she has secured.
Collaborations
Catarina has collaborated with notable colleagues in her field, including Thomas Blankenstein and Matthias Obenaus. These partnerships have further enriched her research and contributed to the development of innovative solutions in cancer therapy.
Conclusion
Catarina Leitão stands out as a leading inventor in the field of cancer immunotherapy. Her innovative patents and collaborative efforts reflect her commitment to advancing medical science and improving treatment options for cancer patients.